| Multisequence Multiparametric MRI-based Radiomics and Pathomics in Prostate Cancer: Towards improved treatment outcomes |
Sneha Singh |
Indian Institute of Technology, Mandi |
PLCO |
Jun 7, 2024 |
PLCO-1588 |
| Socio-economic factors for colorectal cancer in USA |
Subhajit Chakrabarty |
Louisiana State University Shreveport |
PLCO |
Jun 7, 2024 |
PLCO-1583 |
| Ovarian Cancer Research |
Amanda Brooks |
Rocky Vista University |
PLCO |
Jun 7, 2024 |
PLCO-1585 |
| Adherence to the 2018 World Cancer Research Fund (WCRF)/American Institute for Cancer Research (AICR) Cancer Prevention Recommendations and risk of lifestyle-related cancers in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial |
Erikka Loftfield |
Erikka Loftfield Cronin |
PLCO |
Jun 7, 2024 |
PLCO-1584 |
| AI-based multi-dimensional characterization of pulmonary nodules to improve lung cancer screening |
Francesco Sforazzini |
Siena Imaging SRL |
NLST |
May 29, 2024 |
NLST-1257 |
| Predictive model ( AI/ML) of post surgery prognosis of breast cancer using PLCO dataset patient data |
Juri Baruah |
Quantum Biosciences |
PLCO |
May 29, 2024 |
PLCO-1572 |
| Mortality Reduction by year |
Rowena Yip |
Mount Sinai School of Medicine |
PLCO |
May 29, 2024 |
PLCOI-1574 |
| Predicting mortality risk using cardiac LDCT regions |
chen yingchi |
National Yang Ming Chiao Tung University |
NLST |
May 16, 2024 |
NLST-1255 |
| Using foundation model for cardiovascular disease detection. |
Xiaofeng Yang |
Emory University |
NLST |
May 16, 2024 |
NLST-1249 |
| Nodule risk assessment |
Scott Morris |
Maverix Medical |
NLST |
May 16, 2024 |
NLST-1252 |
| Underlying risk of developing and dying from lung cancer |
Louise Henderson |
University of North Carolina at Chapel Hill |
NLST |
May 16, 2024 |
NLST-1248 |
| Comparing Non-Malignancy Rate Definitions Utilizing the NLST Cohort |
Christopher Caruso |
University of Pennsylvania |
NLST |
May 16, 2024 |
NLST-1245 |
| Leveraging Machine Learning for Gynecologic Cancer Diagnosis: Visual Question Answering |
Elham Dolatabadi |
York University |
PLCO |
May 14, 2024 |
PLCOI-1557 |
| Validate Colon Cancer Model trained on synthetic data against PLCO dataset patient data |
Jeremy Howard |
Lucem Health, Inc. |
PLCO |
May 14, 2024 |
PLCO-1553 |
| Biomarker-assisted Decision Rule for Risk Classification under a positive predictive value - constraint: Application to disease screening |
Yingqi Zhao |
Fred Hutchinson Cancer Center |
PLCO |
May 14, 2024 |
PLCO-1556 |
| Heterogeneous treatment effect estimation using instrumental variable in time-to-event data |
Uri Shalit |
Technion - Israel Institute of Technology |
HIPB |
May 13, 2024 |
HIPB-13 |
| AI Modeling Project for Predicting Treatment Response in Non-Small Cell Lung Cancer |
Anna Gracia Colmenarejo |
Universidad Internacional de La Rioja |
PLCO |
Apr 29, 2024 |
PLCO-1542 |
| How effective is PSA Screening as a mode of prevention for Prostate Cancer in Men over the age of 50? |
Jiana Karthikeyan |
Franconian International School |
PLCO |
Apr 29, 2024 |
PLCO-1543 |
| A novel accuracy metric for general M-class classification when subclasses are involved |
Nan Nan |
State University of New York at Buffalo |
PLCO |
Apr 29, 2024 |
PLCO-1531 |
| Development and Validation of In-House Artificial Intelligence Models for Mutation and Survival Prediction |
Nikolaos Tsiknakis |
Karolinska Institutet |
PLCO |
Apr 29, 2024 |
PLCOI-1539 |
